Tharimmune

Biotechnology company(THAR)

A propos de Tharimmune

Tharimmune, Inc. (THAR) is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology.

Communauté
Website
Étiquettes
Digital Asset Treasury
Publicly listed company
Crypto Stocks

Trend of Hot Index Change

Investisseurs

Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest

Détails du financement

Post-IPO(2025-11-03)
Montant€466,45M
Investisseurs
Liberty City Ventures
Liberty City Ventures
DRW Venture Capital
DRW Venture Capital
Kraken
Kraken
Polychain
Polychain
ARK Invest
ARK Invest
Estimation--